Drug Type Monoclonal antibody |
Synonyms anti-FSTL1 mAbs (National Cancer Center) |
Target |
Action inhibitors |
Mechanism FSTL1 inhibitors(Follistatin related protein 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteosarcoma | Preclinical | Japan | - | |
Solid tumor | Preclinical | Japan | - | |
Solid tumor | Preclinical | Japan | - |